Skip to content

Recursion Pharmaceuticals, Inc. RXRX Prepaid & Other Current

Prepaid & Other Current at other companies

Absci Corporation logo
Absci CorporationABSI
$6.27M+38.2%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
$98.1M+3.6%
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
$11.84M-46.1%
Septerna, Inc. logo
Septerna, Inc.SEPN
$9.82M+57.9%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
$3.91M-26.2%
Arrowhead Research logo
Arrowhead ResearchARWR
$21.72M-8.6%

Other financials

Income statement

See full
Revenue$6.5M-56.1%
Gross profit-$6.0M+15.0%
Operating income-$128.5M+32.8%
Net income-$117.5M+42.0%
EPS (diluted)-$0.22+56.0%

Balance sheet

See full
Cash & equivalents$665.2M+30.6%
Total debt$88.6M-24.6%
Total equity$1.0B+9.7%
Total assets$1.3B+2.6%

Cash flow

See full
Operating cash flow-$81.1M+38.5%
CapEx$258.0K-85.9%
Free cash flow-$81.4M+39.2%

Valuation

See full
Market cap$1.71B-23.7%

Profitability

See full
Gross margin7.2%
Operating margin-881.3%-66.8pp
Net margin-842.9%-92.4pp
FCF margin-490.7%-102pp

Returns & leverage

See full
Return on equity-57.2%-14.4pp
Debt / equity0.1×0.0×
Current ratio5.5×+1.4×

Where this comes from

Reported directly by Recursion Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PrepaidExpenseCurrent.

The official record: Recursion Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Recursion Pharmaceuticals, Inc.'s prepaid & other current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Recursion Pharmaceuticals, Inc.'s prepaid & other current?
Recursion Pharmaceuticals, Inc. (RXRX) reported prepaid & other current of $11.74M in Q1 2026.
How has Recursion Pharmaceuticals, Inc.'s prepaid & other current changed year-over-year?
Recursion Pharmaceuticals, Inc.'s prepaid & other current increased by 375.4% year-over-year, from $2.47M to $11.74M.
What is the long-term trend for Recursion Pharmaceuticals, Inc.'s prepaid & other current?
Over 5 years (2020 to 2025), Recursion Pharmaceuticals, Inc.'s prepaid & other current has grown at a 40.4% compound annual growth rate (CAGR), from $2.16M to $11.74M.
What does prepaid & other current mean?
Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.